Fielmann Aktiengesellschaft (FIE.DE)
EUR 43.95
(-0.9%)
EUR 43.95
(-0.9%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 289.86 Million EUR | -76.19% |
| 2022 | 1.21 Billion EUR | 30.17% |
| 2021 | 935.38 Million EUR | -3.25% |
| 2020 | 966.79 Million EUR | 0.61% |
| 2019 | 960.95 Million EUR | 7.97% |
| 2018 | 889.98 Million EUR | 4.11% |
| 2017 | 854.81 Million EUR | 4.68% |
| 2016 | 816.61 Million EUR | 3.38% |
| 2015 | 789.87 Million EUR | 7.1% |
| 2014 | 737.54 Million EUR | 4.09% |
| 2013 | 708.54 Million EUR | 5.07% |
| 2012 | 674.34 Million EUR | 4.05% |
| 2011 | 648.08 Million EUR | 6.56% |
| 2010 | 608.16 Million EUR | 15.84% |
| 2009 | 525 Million EUR | 207.66% |
| 2008 | -487.67 Million EUR | -206.24% |
| 2007 | 459.04 Million EUR | 63.58% |
| 2006 | 280.62 Million EUR | 642.61% |
| 2005 | -51.71 Million EUR | 86.74% |
| 2004 | -389.99 Million EUR | -31.31% |
| 2003 | -297 Million EUR | -24.42% |
| 2002 | -238.72 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 365.12 Million EUR | 1.2% |
| 2024 Q1 | 360.78 Million EUR | 23.34% |
| 2023 Q4 | 292.52 Million EUR | -14.56% |
| 2023 Q3 | 342.37 Million EUR | 3.79% |
| 2023 Q2 | 329.86 Million EUR | 2.3% |
| 2023 FY | 289.86 Million EUR | -76.19% |
| 2023 Q1 | 322.45 Million EUR | 1.44% |
| 2022 Q3 | 308.18 Million EUR | 1.68% |
| 2022 FY | 1.21 Billion EUR | 30.17% |
| 2022 Q2 | 303.1 Million EUR | 5.1% |
| 2022 Q1 | 288.41 Million EUR | 143.15% |
| 2022 Q4 | 317.87 Million EUR | 3.14% |
| 2021 Q4 | 118.61 Million EUR | -57.19% |
| 2021 FY | 935.38 Million EUR | -3.25% |
| 2021 Q1 | 269.17 Million EUR | -28.27% |
| 2021 Q2 | 226.55 Million EUR | -15.83% |
| 2021 Q3 | 277.09 Million EUR | 22.31% |
| 2020 Q1 | 223.09 Million EUR | -69.98% |
| 2020 Q2 | 160.97 Million EUR | -27.85% |
| 2020 Q3 | 207.46 Million EUR | 28.88% |
| 2020 FY | 966.79 Million EUR | 0.61% |
| 2020 Q4 | 375.26 Million EUR | 80.88% |
| 2019 Q3 | 205.05 Million EUR | -1.54% |
| 2019 Q2 | 208.25 Million EUR | -5.16% |
| 2019 Q1 | 219.57 Million EUR | -3.08% |
| 2019 FY | 960.95 Million EUR | 7.97% |
| 2019 Q4 | 743.06 Million EUR | 262.37% |
| 2018 Q1 | 220.02 Million EUR | 5.75% |
| 2018 FY | 889.98 Million EUR | 4.11% |
| 2018 Q2 | 228.57 Million EUR | 3.89% |
| 2018 Q3 | 214.82 Million EUR | -6.02% |
| 2018 Q4 | 226.55 Million EUR | 5.46% |
| 2017 Q2 | 219.22 Million EUR | 0.69% |
| 2017 Q3 | 209.8 Million EUR | -4.3% |
| 2017 Q4 | 208.06 Million EUR | -0.83% |
| 2017 Q1 | 217.72 Million EUR | 6.12% |
| 2017 FY | 854.81 Million EUR | 4.68% |
| 2016 Q4 | 205.17 Million EUR | 2.49% |
| 2016 Q3 | 200.19 Million EUR | -3.14% |
| 2016 Q2 | 206.69 Million EUR | 1.05% |
| 2016 Q1 | 204.54 Million EUR | 4.77% |
| 2016 FY | 816.61 Million EUR | 3.38% |
| 2015 Q2 | 204.29 Million EUR | 3.41% |
| 2015 Q4 | 195.22 Million EUR | 1.26% |
| 2015 Q3 | 192.8 Million EUR | -5.62% |
| 2015 FY | 789.87 Million EUR | 7.1% |
| 2015 Q1 | 197.55 Million EUR | 9.79% |
| 2014 Q2 | 190.72 Million EUR | 0.17% |
| 2014 Q3 | 176.5 Million EUR | -7.46% |
| 2014 Q4 | 179.93 Million EUR | 1.94% |
| 2014 FY | 737.54 Million EUR | 4.09% |
| 2014 Q1 | 190.39 Million EUR | 7.47% |
| 2013 Q3 | 171.52 Million EUR | -5.97% |
| 2013 Q1 | 177.43 Million EUR | 4.47% |
| 2013 FY | 708.54 Million EUR | 5.07% |
| 2013 Q4 | 177.16 Million EUR | 3.28% |
| 2013 Q2 | 182.42 Million EUR | 2.81% |
| 2012 FY | 674.34 Million EUR | 4.05% |
| 2012 Q1 | 170.19 Million EUR | 1.99% |
| 2012 Q2 | 169.52 Million EUR | -0.39% |
| 2012 Q3 | 164.79 Million EUR | -2.79% |
| 2012 Q4 | 169.83 Million EUR | 3.06% |
| 2011 Q3 | 157.64 Million EUR | -1.91% |
| 2011 Q2 | 160.71 Million EUR | -1.31% |
| 2011 Q1 | 162.85 Million EUR | -17.8% |
| 2011 FY | 648.08 Million EUR | 6.56% |
| 2011 Q4 | 166.86 Million EUR | 5.85% |
| 2010 FY | 608.16 Million EUR | 15.84% |
| 2010 Q4 | 198.1 Million EUR | 48.96% |
| 2010 Q3 | 132.99 Million EUR | -3.4% |
| 2010 Q2 | 137.67 Million EUR | -1.23% |
| 2010 Q1 | 139.38 Million EUR | 5.69% |
| 2009 Q1 | 132.48 Million EUR | 0.0% |
| 2009 Q2 | 132.05 Million EUR | -0.33% |
| 2009 Q4 | 131.88 Million EUR | 2.56% |
| 2009 FY | 525 Million EUR | 207.66% |
| 2009 Q3 | 128.58 Million EUR | -2.62% |
| 2008 FY | -487.67 Million EUR | -206.24% |
| 2007 FY | 459.04 Million EUR | 63.58% |
| 2006 FY | 280.62 Million EUR | 642.61% |
| 2005 FY | -51.71 Million EUR | 86.74% |
| 2004 FY | -389.99 Million EUR | -31.31% |
| 2003 FY | -297 Million EUR | -24.42% |
| 2002 FY | -238.72 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 124.1 Million EUR | -133.562% |
| Carl Zeiss Meditec AG | 878.62 Million EUR | 67.009% |
| Gerresheimer AG | 383.92 Million EUR | 24.499% |
| Sartorius Aktiengesellschaft | 1.02 Billion EUR | 71.69% |
| Sartorius Aktiengesellschaft | 1.02 Billion EUR | 71.651% |